Tyche Industries Ltd. | Small-cap | Healthcare
₹143.00
-0.73%
| Tyche Industries Stock Comparison:
Tyche Industries vs Sun PharmaceuticalTyche Industries vs Divi's LaboratoriesTyche Industries vs Suven Life SciencesTyche Industries vs Sequent ScientificTyche Industries vs Aarti DrugsTyche Industries vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 127.0M
Gross Profit 87.5M 68.87%
Operating Income 14.9M 11.77%
Net Income 24.3M 19.15%
EPS (Diluted) ₹2.37

Balance Sheet Metrics

Total Assets 1.5B
Total Liabilities 107.1M
Shareholders Equity 1.4B
Debt to Equity 0.08

Cash Flow Metrics

Revenue & Profitability Trend

Tyche Industries Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i654.7M695.1M753.9M622.7M782.4M
Cost of Goods Sold i364.0M410.5M433.8M367.2M395.3M
Gross Profit i290.7M284.6M320.0M255.4M387.1M
Gross Margin % i44.4%40.9%42.5%41.0%49.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i66.2M45.7M50.3M50.6M40.4M
Other Operating Expenses i11.2M13.9M14.0M11.2M7.6M
Total Operating Expenses i77.3M59.6M64.2M61.8M48.0M
Operating Income i100.3M108.8M145.9M99.0M241.5M
Operating Margin % i15.3%15.7%19.4%15.9%30.9%
Non-Operating Items
Interest Income i60.4M50.5M36.9M30.4M29.2M
Interest Expense i000069.0K
Other Non-Operating Income-----
Pre-tax Income i167.1M166.3M190.8M126.4M267.3M
Income Tax i43.1M43.9M49.1M33.0M67.5M
Effective Tax Rate % i25.8%26.4%25.7%26.2%25.3%
Net Income i124.1M122.4M141.7M93.3M199.8M
Net Margin % i19.0%17.6%18.8%15.0%25.5%
Key Metrics
EBITDA i186.8M185.7M209.8M123.4M294.5M
EPS (Basic) i₹12.20₹11.95₹13.83₹9.11₹19.51
EPS (Diluted) i₹12.20₹11.95₹13.83₹9.11₹19.51
Basic Shares Outstanding i1024500010245000102450001024500010245000
Diluted Shares Outstanding i1024500010245000102450001024500010245000

Income Statement Trend

Tyche Industries Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i39.8M39.7M67.2M35.9M73.0M
Short-term Investments i772.2M718.0M625.7M621.9M522.8M
Accounts Receivable i171.2M191.2M220.8M164.2M171.3M
Inventory i166.4M125.6M179.7M112.4M109.5M
Other Current Assets1.0K1.0K71.2M1.0K-1.0K
Total Current Assets i1.2B1.1B1.1B1.0B963.2M
Non-Current Assets
Property, Plant & Equipment i68.2M63.8M53.6M53.2M51.4M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets2.0K20.0M2.7M-18.6M99.0K
Total Non-Current Assets i264.7M238.5M242.7M192.4M206.3M
Total Assets i1.5B1.4B1.4B1.2B1.2B
Liabilities
Current Liabilities
Accounts Payable i58.0M38.3M123.8M59.0M68.8M
Short-term Debt i0000-
Current Portion of Long-term Debt-----
Other Current Liabilities1.0K9.7M1.0K21.1M17.8M
Total Current Liabilities i96.2M66.8M165.7M128.3M177.9M
Non-Current Liabilities
Long-term Debt i00000
Deferred Tax Liabilities i10.8M11.7M12.4M13.6M14.5M
Other Non-Current Liabilities-2.0K-1.0K18.6M17.5M
Total Non-Current Liabilities i10.8M34.8M33.9M32.2M32.0M
Total Liabilities i107.1M101.6M199.6M160.5M209.9M
Equity
Common Stock i102.5M102.5M102.5M102.5M102.5M
Retained Earnings i1.2B1.1B994.2M870.8M791.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.4B1.3B1.2B1.0B959.6M
Key Metrics
Total Debt i00000
Working Capital i1.1B1.1B958.7M882.0M785.3M

Balance Sheet Composition

Tyche Industries Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i168.2M163.9M189.5M127.3M265.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i5.2M43.5M-130.0M21.6M-51.5M
Operating Cash Flow i113.0M157.0M22.5M118.5M184.6M
Investing Activities
Capital Expenditures i-7.2M-32.3M-17.5M-9.9M-25.0M
Acquisitions i-----
Investment Purchases i-59.6M--50.7M--
Investment Sales i-21.2M---
Investing Cash Flow i-66.6M-11.1M-68.2M1.2M-25.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-25.6M-20.5M-15.4M-10.2M-10.2M
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-25.6M-20.5M-30.7M-20.5M-20.5M
Free Cash Flow i78.2M44.8M46.8M34.7M129.5M
Net Change in Cash i20.7M125.4M-76.4M99.2M139.1M

Cash Flow Trend

Tyche Industries Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 11.90
Forward P/E 24.52
Price to Book 0.98
Price to Sales 2.32
PEG Ratio -1.09

Profitability Ratios

Profit Margin 19.33%
Operating Margin 11.77%
Return on Equity 9.08%
Return on Assets 8.42%

Financial Health

Current Ratio 12.57
Debt to Equity 0.00
Beta 0.14

Per Share Data

EPS (TTM) ₹11.91
Book Value per Share ₹144.76
Revenue per Share ₹61.53

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
tyche1.5B11.900.989.08%19.33%0.00
Sun Pharmaceutical 3.9T36.745.3015.08%19.29%3.26
Divi's Laboratories 1.6T65.3610.0914.64%23.89%0.03
Suven Life Sciences 48.2B-28.0140.49-146.15%84.44%0.00
Sequent Scientific 48.1B166.336.612.84%1.85%62.47
Aarti Drugs 44.5B23.663.2612.28%7.80%44.92

Financial data is updated regularly. All figures are in the company's reporting currency.